Implementing in Practice

First introduced globally in 2008, Selenia Dimensions breast tomosynthesis holds many exciting clinical possibilities to help find and fight breast cancer earlier than ever before. The majority of clinical studies show the future potential of using Hologic’s breast tomosynthesis is in screening; all patients, regardless of dense or fatty breasts, are found to benefit from tomosynthesis1-2. However, implementation paths may vary depending on the number of tomosynthesis systems available at the site.

Please contact your Hologic territory manager to discuss options.

print email

Sources

1. Skaane P. et. al. Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening Program. Radiology. 2013 Jan 7 [Epub ahead of print]. 2. Rafferty EA, Niklason L. FFDM versus FFDM with tomosynthesis for women with radiologically dense breasts: an enriched retrospective reader study. Radiological Society of North America annual meeting. Chicago, Il, 2011

Hologic - Contact Us

contact us

Hologic N.V.
Leuvensesteenweg 250A
1800 Vilvoorde
Belgium
Tel: +32.2.711.4680